+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Groenlandicine

BP3171
38691-95-1
98%
Phytounique
Groenlandicine may be a promising anti-Alzheimer's disease agent due to its potent inhibitory activity of both ChEs and beta-amyloids formation, as well as marked ONOO(-) scavenging and good ROS inhibitory capacities. Groenlandicine exhibits moderate inhibitory effects with the IC(50) value of 140.1 microM for rat lens aldose reductase (RLAR) and 154.2 microM for human recombinant AR (HRAR), it has beneficial uses in the development of therapeutic and preventive agents for diabetic complications and diabetes mellitus. Groenlandicine is a active principle with topoisomerase I-mediated DNA cleavage activity in vitro. Groenlandicine has bitter, and also has antibacterial activity on E. coli and S. aureus,there was close relationship between the bitter degree and antibacterial activity of bitter components.
Catalog No Package Original Price Price Inventory Quantity Operating
BP3171-5mg 5mg
BP3171-10mg 10mg
BP3171-20mg 20mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

AKR1B1 NFE2L2 GSK3B TP53 CASP3 SOD1
BCL2 TP53 CDK2 CASP3 BAX
NFE2L2 TP53 SOD1 HMOX1 KEAP1

Product drug property prediction parameters

  • 51.8000

  • .2605

  • .2153

  • .3794

  • .9107

  • 17.9889

  • High

  • 33.4571

  • 2.9753

  • Yes

  • No

  • No

  • No

  • Yes

  • Yes

  • 2.4

  • No

  • No

  • No

  • No